Title | Novel Cephalosporins Selectively Active on Nonreplicating Mycobacterium tuberculosis. |
Publication Type | Journal Article |
Year of Publication | 2016 |
Authors | Gold B, Smith R, Nguyen Q, Roberts J, Ling Y, Quezada LLopez, Somersan S, Warrier T, Little D, Pingle M, Zhang D, Ballinger E, Zimmerman M, Dartois V, Hanson P, Mitscher LA, Porubsky P, Rogers S, Schoenen FJ, Nathan C, Aubé J |
Journal | J Med Chem |
Volume | 59 |
Issue | 13 |
Pagination | 6027-44 |
Date Published | 2016 Jul 14 |
ISSN | 1520-4804 |
Keywords | Animals, Antitubercular Agents, Cells, Cultured, Cephalosporins, Female, Hep G2 Cells, Humans, Macrophages, Mice, Mice, Inbred C57BL, Microbial Sensitivity Tests, Microsomes, Liver, Mycobacterium tuberculosis, Structure-Activity Relationship, Tuberculosis |
Abstract | We report two series of novel cephalosporins that are bactericidal to Mycobacterium tuberculosis alone of the pathogens tested, which only kill M. tuberculosis when its replication is halted by conditions resembling those believed to pertain in the host, and whose bactericidal activity is not dependent upon or enhanced by clavulanate, a β-lactamase inhibitor. The two classes of cephalosporins bear an ester or alternatively an oxadiazole isostere at C-2 of the cephalosporin ring system, a position that is almost exclusively a carboxylic acid in clinically used agents in the class. Representatives of the series kill M. tuberculosis within macrophages without toxicity to the macrophages or other mammalian cells. |
DOI | 10.1021/acs.jmedchem.5b01833 |
Alternate Journal | J. Med. Chem. |
PubMed ID | 27144688 |
PubMed Central ID | PMC4947980 |
Grant List | U19 AI111143 / AI / NIAID NIH HHS / United States K08 AI108799 / AI / NIAID NIH HHS / United States P30 RR030926 / RR / NCRR NIH HHS / United States U54 HG005031 / HG / NHGRI NIH HHS / United States P50 GM069663 / GM / NIGMS NIH HHS / United States |
Submitted by alp2017 on October 2, 2017 - 3:40pm